Research ArticleRheumatoid Arthritis
Gastrointestinal Adverse Drug Reaction Profile of Etanercept: Real-world Data From Patients and Healthcare Professionals
Jette A. van Lint, Naomi T. Jessurun, Sander W. Tas, Bart J.F. van den Bemt, Michael T. Nurmohamed, Martijn B.A. van Doorn, Phyllis I. Spuls, Astrid M. van Tubergen, Peter M. ten Klooster, Eugene P. van Puijenbroek, Frank Hoentjen and Harald E. Vonkeman
The Journal of Rheumatology September 2021, 48 (9) 1388-1394; DOI: https://doi.org/10.3899/jrheum.201373
Jette A. van Lint
1J.A. van Lint, PharmD, N.T. Jessurun, PharmD, Netherlands Pharmacovigilance Centre Lareb, ’s-Hertogenbosch;
Naomi T. Jessurun
1J.A. van Lint, PharmD, N.T. Jessurun, PharmD, Netherlands Pharmacovigilance Centre Lareb, ’s-Hertogenbosch;
Sander W. Tas
2S.W. Tas, MD, PhD, Department of Rheumatology & Clinical Immunology, Amsterdam UMC, location Academic Medical Center, University of Amsterdam, Amsterdam Infection & Immunity Institute and Amsterdam Rheumatology & immunology Center (ARC), Amsterdam;
Bart J.F. van den Bemt
3B.J.F. van den Bemt, PharmD, Prof. Dr., Department of Pharmacy, Sint Maartenskliniek, and Department of Pharmacy, Radboud University Medical Center, Nijmegen;
Michael T. Nurmohamed
4M.T. Nurmohamed, MD, Prof. Dr., Amsterdam Rheumatology & immunology Center (ARC), Reade, and Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, VU University Medical Center, Amsterdam;
Martijn B.A. van Doorn
5M.B. van Doorn, MD, PhD, Department of Dermatology, Erasmus MC, University Medical Center, Rotterdam;
Phyllis I. Spuls
6P.I. Spuls, MD, Prof. Dr., Department of Dermatology, Public Health and Epidemiology, Immunity and Infections, Amsterdam UMC, location Academic Medical Center, Amsterdam;
Astrid M. van Tubergen
7A.M. van Tubergen, MD, Prof. Dr., Department of Rheumatology, Maastricht University Medical Center, and Care and Public Health Research Institute (CAPHRI), Maastricht University, Maastricht;
Peter M. ten Klooster
8P.M. ten Klooster, PhD, Transparency in Healthcare BV, Hengelo, and Department of Psychology, Health & Technology, University of Twente, Enschede;
Eugene P. van Puijenbroek
9E.P. van Puijenbroek, MD, Prof. Dr., Netherlands Pharmacovigilance Centre Lareb, ’s-Hertogenbosch, and Department of Pharmacotherapy, Epidemiology & Economics, University of Groningen, Groningen;
Frank Hoentjen
10F. Hoentjen, MD, PhD, Department of Gastroenterology, Radboud University Medical Center, Nijmegen;
Harald E. Vonkeman
11H.E. Vonkeman, MD, PhD, Department of Psychology, Health & Technology, University of Twente, and Department of Rheumatology and Clinical Immunology, Medisch Spectrum Twente, Enschede, the Netherlands.
REFERENCES
- 1.↵
- Tank ND,
- Karelia BN,
- Vegada BN
- 2.↵
- European Medicines Agency
- 3.↵
- European Medicines Agency
- 4.↵
- European Medicines Agency
- 5.↵
- Verazza S,
- Davì S,
- Consolaro A,
- Bovis F,
- Insalaco A,
- Magni-Manzoni S, et al; Italian Pediatric Rheumatology Study Group
- 6.↵
- Hutchings D,
- Miller JA,
- Voltaggio L
- 7.↵
- Forouzandeh M,
- Vazquez T,
- Nouri K,
- Forouzandeh B
- 8.
- Tolu S,
- Rezvani A,
- Hindioglu N,
- Calkin Korkmaz M
- 9.
- Flemming GM,
- Tóth G,
- Gebauer C,
- Schuster V
- 10.
- 11.
- 12.↵
- 13.↵
- van Lint JA,
- Jessurun N,
- Hebing RCF,
- Hoentjen F,
- Tas SW,
- Vonkeman HE, et al.
- 14.↵
- Basch E
- 15.↵
- Kosse LJ,
- Jessurun N,
- Hebing RCF,
- Huiskes VJB,
- Spijkers KM,
- van den Bemt BJF, et al.
- 16.↵
- 17.↵
- Webers C,
- Beckers E,
- Boonen A,
- van Eijk-Hustings Y,
- Vonkeman H,
- van de Laar M, et al.
- 18.↵
- Giraud EL,
- Jessurun NT,
- van Hunsel FPAM,
- van Puijenbroek EP,
- van Tubergen A,
- ten Klooster PM, et al.
- 19.↵
- 20.↵
- Kievit W,
- Fransen J,
- Oerlemans AJ,
- Kuper HH,
- van der Laar MA,
- de Rooij DJ, et al.
- 21.↵
- 22.↵
- Steunebrink LM,
- Versteeg GA,
- Vonkeman HE,
- ten Klooster PM,
- Kuper HH,
- Zijlstra TR, et al.
- 23.↵
- Bankowski Z,
- Bruppacher R,
- Crusius I,
- Gallagher J,
- Kremer G,
- Venulet J
- 24.↵
- Medical Dictionary for Regulatory Activities
- 25.↵
- 26.↵
- 27.↵
- Bieber A,
- Fawaz A,
- Novofastovski I,
- Mader R
- 28.↵
- 29.↵
- 30.↵
- Korzenik J,
- Larsen MD,
- Nielsen J,
- Kjeldsen J,
- Nørgård BM
- 31.↵
- Barthel D,
- Ganser G,
- Kuester RM,
- Onken N,
- Minden K,
- Girschick HJ, et al.
- 32.↵
- Craig E,
- Cappelli LC
- 33.↵
- Wood PR,
- Caplan L
- 34.↵
In this issue
The Journal of Rheumatology
Vol. 48, Issue 9
1 Sep 2021
Gastrointestinal Adverse Drug Reaction Profile of Etanercept: Real-world Data From Patients and Healthcare Professionals
Jette A. van Lint, Naomi T. Jessurun, Sander W. Tas, Bart J.F. van den Bemt, Michael T. Nurmohamed, Martijn B.A. van Doorn, Phyllis I. Spuls, Astrid M. van Tubergen, Peter M. ten Klooster, Eugene P. van Puijenbroek, Frank Hoentjen, Harald E. Vonkeman
The Journal of Rheumatology Sep 2021, 48 (9) 1388-1394; DOI: 10.3899/jrheum.201373
Gastrointestinal Adverse Drug Reaction Profile of Etanercept: Real-world Data From Patients and Healthcare Professionals
Jette A. van Lint, Naomi T. Jessurun, Sander W. Tas, Bart J.F. van den Bemt, Michael T. Nurmohamed, Martijn B.A. van Doorn, Phyllis I. Spuls, Astrid M. van Tubergen, Peter M. ten Klooster, Eugene P. van Puijenbroek, Frank Hoentjen, Harald E. Vonkeman
The Journal of Rheumatology Sep 2021, 48 (9) 1388-1394; DOI: 10.3899/jrheum.201373